Developing a new test to monitor cell activity and disease progression in MS

prof-jonathon-baell

Professor Jonathon Baell

Monash University, VIC

| Causes and Prevention | Neurobiology | Project | 2021 | Investigator Led Research |
SUPPORT PROJECTS WITH THIS RESEARCH FOCUS

Summary

Being able to correctly monitor the level of MS activity is always important in clinical care, but particularly so during a clinical drug trial where the ability of a new drug to stop MS activity is being assessed. Currently, monitoring progression of MS over time in clinical trials is challenging and there is no one test which can accurately make that assessment.

We currently know that as MS progresses, inflammatory cells within the brain called microglia are active, and likely to be contributing to disease progression over time. However, there are different types of microglia, pathogenic (indicating active disease) and reparative (indicating a repairing phase and less disease activity). At present, there is no way to distinguish between the two types of microglia to measure the microglial response and to know if MS progression is occurring.

Professor Baell and his team aim to develop techniques to identify both the extent and the nature of this microglial response. They plan on doing this by developing a new additive to be used in a non-invasive PET (positron emission tomography) scan to determine the level of disease activity and MS progression. This could help fill an unmet need in clinical trials for new MS drugs by helping to identify effective drugs to treat progressive MS sooner and more accurately.

Updated 20 January 2021

Updated: 19 January, 2021

Stages of the research process

Fundamental laboratory
Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline: 10+ years
Translational
Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline: 5+ years
Clinical Studies
and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline: 1-5 years
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search